基层医疗抗菌药物管理的经济学评价:系统综述与质量评估
该系统综述检索2010至2020年Medline、Embase、EconLit和Web of Science数据库,纳入12项基层医疗抗菌药物管理(AMS)干预的经济学评价研究(8项基于试验、4项模型评价)。6项研究认为AMS干预具有成本效果,另6项报告无成本效果或结论不确定;沟通技能培训和C反应蛋白即时检测(CRP-POCT)常具成本效果或成本效益。
要点
- 基层医疗占抗菌药物处方的80%-90%,是AMS干预的重要场所。
- 12项研究中6项报告AMS干预具成本效果,6项报告无成本效果或结论不确定。
- 沟通技能培训与CRP-POCT常具成本效果或成本效益,但各研究间存在显著差异。
核心结论
- AMS干预的成本效果在各研究间存在显著差异,并取决于是否纳入抗菌药物耐药成本等成本组成部分。
- 沟通技能培训和CRP-POCT在减少不适当抗菌药物处方方面常具成本效果或成本效益。
研究设计与样本
- 系统综述,检索Medline、Embase、EconLit和Web of Science数据库2010至2020年发表的文献。
- 共识别2722条记录,最终纳入12项研究,其中8项为基于试验的评价、4项为模型评价。
- 采用健康经济评价共识清单(Consensus on Health Economic Criteria checklist)和卫生技术评估决策分析模型良好实践指南评估研究质量。
主要发现
- 最常见的AMS干预为针对卫生专业人员的沟通技能培训和C反应蛋白即时检测(CRP-POCT)。
- 经济学评价类型包括成本效果分析(7项)、成本效用分析(1项)、成本效益分析(2项)、成本效果与成本效用分析(1项)和成本分析(1项)。
- 6项研究发现AMS干预具成本效果,另6项报告无成本效果或结论不确定。
- 研究质量从良好到低不等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary care accounts for 80%-90% of antimicrobial prescriptions, making this setting an important focus for antimicrobial stewardship (AMS) interventions. OBJECTIVES: To collate the findings and critically appraise the qualities of economic evaluation studies of AMS or related interventions aimed at reducing inappropriate antimicrobial prescribing in primary care. METHODS: A systematic review of economic evaluations of interventions aimed at reducing inappropriate antimicrobial prescribing in primary care was performed. Published literature were retrieved through a search of Medline, Embase, EconLit and Web of Science databases for the period 2010 to 2020. The quality of the studies was assessed using the Consensus on Health Economic Criteria checklist and Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment. RESULTS: Of the 2722 records identified, 12 studies were included in the review (8 trial-based and 4 modelled evaluations). The most common AMS interventions were communication skills training for health professionals and C-reactive protein point-of-care testing (CRP-POCT). Types of economic evaluations included in the review were cost-effectiveness (7 studies), cost-utility (1), cost-benefit (2), cost-effectiveness and cost-utility (1) and cost analysis (1). While six of the studies found AMS interventions to be cost-effective, the other six reported them as not cost-effective or inconclusive. The quality of the studies ranged from good to low. CONCLUSIONS: There were significant variations in cost-effectiveness of AMS interventions across studies and depending on the inclusion of cost components such as the cost of antimicrobial resistance. However, communication skills training and CRP-POCT were frequently cost-effective or cost-beneficial for reducing inappropriate antimicrobial prescribing.
引用
- Wubishet BL, Merlo G, Ghahreman-Falconer N, et al. Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment. J Antimicrob Chemother. 2022. PMID: 35724206. doi:10.1093/jac/dkac185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。